# Georgiamune

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/georgiamune

- Industry: Biotechnology
- Headquarters: Gaithersburg, US
- Website: www.georgiamune.com
- Total disclosed funding: $68M
- Latest round: Series A (Feb 22, 2023)
- Investors on record: 7

## About

Based in Maryland, US, and founded in 2017 by CEO Samir Khleif, Georgiamune Inc. operates as a biotechnology company providing immunotherapeutic and immune signaling pathways to fight diseases. In August 2023, Georgiamune Inc. raised USD 75 million in venture funding co-led by General Catalyst Partners and Parker Institute for Cancer Immunotherapy, with participation from Alexandria Venture Investments, Catalio Capital Management, CJNV BioVenture, Mubadala Capital, and Verition Fund Management. 

Georgiamune Inc. provides medical solutions for cancer, autoimmune, antibody, and small molecules such as GIM-122, GIM-531, GIM-407, GIM-0616, GIM-0915, GIM-0710, GIM-0228, and GIM-1213s. The company provides a platform for supporting patients with cancer and autoimmune diseases. In addition, the firm provides research and development services for preclinical and clinical programs.

## Funding rounds

- Series A, Feb 22, 2023, $47M — General Catalyst Partners, Alexandria Venture Investments, Verition Fund Management, Mubadala Capital, Parker Institute for Cancer Immunotherapy, Catalio Capital Management, CJNV BioVenture
- Series A, May 5, 2022, $1.5M — General Catalyst Partners, Alexandria Venture Investments, Verition Fund Management, Mubadala Capital, Parker Institute for Cancer Immunotherapy, Catalio Capital Management, CJNV BioVenture
- Series A, Jun 22, 2021, $20M — General Catalyst Partners, Alexandria Venture Investments, Verition Fund Management, Mubadala Capital, Parker Institute for Cancer Immunotherapy, Catalio Capital Management, CJNV BioVenture

## Investors

- General Catalyst Partners (https://capitalatlas.ai/funds/general-catalyst-partners) — Series A
- Alexandria Venture Investments (https://capitalatlas.ai/funds/alexandria-venture-investments) — Series A
- Verition Fund Management — Series A
- Mubadala Capital (https://capitalatlas.ai/funds/mubadala-capital) — Series A
- Parker Institute for Cancer Immunotherapy — Series A
- Catalio Capital Management (https://capitalatlas.ai/funds/catalio-capital-management) — Series A
- CJNV BioVenture — Series A